Clinical Trials on Advanced Hematologic Malignancies in Finland
Total 459 results
-
Helsinki University Central HospitalRecruitingSolid Tumor | Advanced Cancer | Haematological MalignancyFinland
-
Tampere University HospitalHelsinki University Central Hospital; Tampere University; University of Eastern... and other collaboratorsActive, not recruiting
-
medac GmbHCompletedHematological MalignanciesGermany, Finland, Poland, Sweden
-
Rhode Island HospitalUnknownSolid Tumors | Hematological MalignanciesUnited States
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.Active, not recruitingAdvanced MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Adam OlszewskiActive, not recruitingLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Hematologic Malignancy | MyelomaUnited States
-
Turku University HospitalTurku University of Applied SciencesCompletedAdvanced Cardiac Life SupportFinland
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
Dana-Farber Cancer InstituteCharles H. Hood FoundationRecruitingMyelodysplastic Syndromes | Leukemia | Myeloproliferative SyndromeUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
Northwell HealthCompletedMediastinal Lymphadenopathy | Lung MalignanciesUnited States
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
-
Rhode Island HospitalBrown UniversityRecruiting
-
Regeneron PharmaceuticalsSanofiCompletedMalignanciesUnited States, Korea, Republic of, Australia, Ireland, United Kingdom
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
medac GmbHCompleted
-
Töölö HospitalTurku University Hospital; Tampere University Hospital; Jyväskylä Central Hospital and other collaboratorsRecruitingWrist Osteoarthritis | Scapholunate Advanced CollapseFinland
-
Dextra Fertility ClinicUnknown
-
Bristol-Myers SquibbAgenus Inc.Active, not recruitingAdvanced CancerUnited States
-
TYK Medicines, IncRecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States
-
Kuopio University HospitalCompleted
-
Turku University HospitalUniversity of TurkuActive, not recruitingBenign Prostatic Hyperplasia | Locally Advanced Prostate Cancer | Locally Recurrent Prostate Cancer | Localised Prostate CancerFinland
-
Turku University HospitalHelsinki University Central HospitalCompletedBlood Coagulation DisorderFinland
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Australia
-
Agenus Inc.Active, not recruiting
-
Turku University HospitalUnknown
-
Tampere University HospitalWithdrawnBlood Loss, Surgical | Coagulation Defect; Acquired | Blood Loss Requiring TransfusionFinland
-
BayerCompletedAdvanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)United States, Sweden, Netherlands, United Kingdom, Finland
-
Daiichi SankyoRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Japan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
Tampere University HospitalCompleted
-
Oulu University HospitalCompleted
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasms (MPNs)United States, Spain, Korea, Republic of, France, Taiwan, Australia, Belgium, Singapore, Israel, Canada, Germany, Finland
-
Tampere University HospitalCSL BehringCompletedAneurysmatic Subarachnoid HaemorrhageFinland
-
Tampere University HospitalCarol Davila University of Medicine and PharmacyActive, not recruitingCeliac Disease | Eosinophilic EsophagitisFinland, Romania
-
Repare TherapeuticsRoche Pharma AGActive, not recruitingAdvanced Solid TumorUnited States, Canada, Denmark, United Kingdom
-
Repare TherapeuticsDebiopharm International SARecruitingAdvanced Solid TumorUnited States, Canada, Denmark
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Australia
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Dartmouth-Hitchcock Medical CenterNational Institute of Nursing Research (NINR)Completed